Christopher C. Mader
10Patents
5h-index
12Co-inventors
55Inventor score
Filing activity: Jul 25, 2014 → Aug 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10182988B2 | Liposomal particles, methods of making same and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US10208310B2 | Anti-TNF compounds | Chemistry; Metallurgy | 16 | Active |
| US10792251B2 | Liposomal particles, methods of making same and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US10434064B2 | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications | Human Necessities | 9 | Active |
| US10837018B2 | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use | Emerging Cross-Sectional Technologies | 6 | Active |
| US10894963B2 | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use | Emerging Cross-Sectional Technologies | 5 | Active |
| US11123294B2 | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications | Human Necessities | 5 | Active |
| US10760080B2 | Anti-TNF compounds | Chemistry; Metallurgy | 5 | Active |
| US11883535B2 | Liposomal particles, methods of making same and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11957788B2 | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.